Topical hydrocortisone, the low-strength cream you can buy over the counter for bug bites and rashes, is generally considered one of the safer steroid options during pregnancy. It falls into FDA pregnancy risk category C, meaning animal studies have shown some risk but there aren’t enough well-controlled human studies to give a definitive all-clear. In practice, most doctors will tell you that small amounts of a mild hydrocortisone cream (1% or less) applied to a limited area for a short time pose very little risk to your baby.
That said, the picture is more nuanced than a simple yes or no, and the type of hydrocortisone matters enormously. There’s a big difference between dabbing a thin layer of cream on an itchy patch and taking oral corticosteroids for weeks.
Why Topical Hydrocortisone Is Treated Differently
Hydrocortisone is the weakest class of topical corticosteroid. When you apply it to a small area of skin, very little of the drug actually reaches your bloodstream. Your placenta also has a built-in defense: an enzyme that breaks down cortisol-like compounds before they can cross to the fetus. Because hydrocortisone is structurally similar to the cortisol your body already produces, the placenta metabolizes it efficiently. This combination of low potency and high placental breakdown is the main reason it’s often presumed safe.
A Cochrane review examining topical corticosteroid safety in pregnancy noted that while this assumption is widespread, it’s based on limited direct evidence rather than large, rigorous trials. The reassurance comes mostly from the biology (low absorption, placental metabolism) and from the absence of clear harm signals in the data we do have, not from gold-standard studies proving safety.
The Real Risks Come From Stronger Steroids
Most of the concerning research involves systemic corticosteroids, meaning pills or injections that flood the entire body with much higher doses. The key findings from that research help put topical hydrocortisone in perspective.
First-trimester use of systemic corticosteroids has been linked to a small increase in the odds of cleft lip, with or without cleft palate. Several large studies have estimated that risk at roughly 1.6 to 2.1 times the baseline rate. In real numbers, that would mean the risk goes from about 1.7 per 1,000 live births to roughly 2.7 per 1,000. That’s a meaningful increase in relative terms but still a very small absolute risk, and some studies have not found a statistically significant link at all.
There’s also limited evidence connecting systemic steroid use to preterm birth and restricted fetal growth, though these findings are clouded by the fact that women taking oral steroids typically have serious underlying conditions (like lupus or severe asthma) that themselves carry pregnancy risks. Separating the drug’s effect from the disease’s effect is difficult.
None of these risks have been clearly tied to low-potency topical use. The only case report linking a topical steroid to fetal growth restriction involved a woman using 40 milligrams per day of triamcinolone cream, a much stronger steroid applied in large quantities.
How to Minimize Risk When Using It
If you need hydrocortisone during pregnancy, the general approach is to use the least amount for the shortest time on the smallest area of skin. A helpful measurement: one “fingertip unit,” the amount you can squeeze from the tip of your index finger to the first knuckle, covers roughly 2% of an adult’s body surface. For a small rash, insect bite, or patch of eczema, that’s typically more than enough.
Low-potency topical steroids like hydrocortisone 1% don’t carry the same time limits as stronger formulations. Medium- and high-potency steroids are generally capped at about 12 weeks of continuous use, while the strongest steroids should be limited to three weeks. For over-the-counter hydrocortisone, no strict time limit has been established, but using it only as long as symptoms persist is a reasonable approach during pregnancy.
Avoid applying it to large areas of your body, broken skin, or under occlusive bandages, all of which increase how much gets absorbed into your bloodstream. The thinner the skin (face, groin, armpits), the more gets through, so these areas warrant extra caution.
Topical vs. Oral: A Critical Distinction
It’s worth being clear about terminology, because “hydrocortisone” can refer to very different products. The over-the-counter cream (typically 0.5% to 1%) delivers a tiny dose to one spot on your skin. Oral hydrocortisone tablets or injectable forms deliver the drug systemically at much higher concentrations. If your doctor has prescribed oral hydrocortisone or another systemic corticosteroid during pregnancy, that decision involves a different risk-benefit calculation, usually because the condition being treated (severe autoimmune disease, adrenal insufficiency) poses its own serious risks.
Non-Steroid Options for Common Skin Issues
For mild itching, dryness, or irritation, you can often manage symptoms without steroids at all. Fragrance-free moisturizers applied frequently help with pregnancy-related dry skin and mild eczema. Colloidal oatmeal baths or creams can soothe itching. Cold compresses work well for localized bug bites or contact irritation. If these aren’t enough and you find yourself reaching for hydrocortisone regularly, that’s a reasonable signal to talk with your provider about what’s driving the skin issue.
Using Hydrocortisone While Breastfeeding
Topical hydrocortisone hasn’t been formally studied in breastfeeding, but the same logic applies: such a small amount reaches the bloodstream that it’s unlikely to pass into breast milk in meaningful quantities. Current guidelines allow topical corticosteroids to be applied to the nipples for conditions like eczema, provided you apply the cream right after nursing and gently clean the area before the next feeding. Use a water-based cream or gel rather than an ointment, since ointments contain mineral paraffins that a baby could ingest through licking. Most importantly, make sure your infant’s skin doesn’t come into direct contact with treated areas.